Abstract
Little is known of the lung cellular immunophenotypes in patients with non-tuberculous mycobacterial lung disease (NTM-LD). Flow-cytometric analyses for the major myeloid and lymphoid cell subsets were performed in less- and more-diseased areas of surgically resected lungs from six patients with NTM-LD and two with Pseudomonas aeruginosa lung disease (PsA-LD). Lymphocytes, comprised mainly of NK cells, CD4+ and CD8+ T cells, and B cells, accounted for ~60% of all leukocytes, with greater prevalence of T and B cells in more-diseased areas. In contrast, fewer neutrophils were found with decreased number in more-diseased areas. Compared to NTM-LD, lung tissues from patients with PsA-LD demonstrated relatively lower numbers of T and B lymphocytes but similar numbers of NK cells. While this study demonstrated a large influx of lymphocytes into the lungs of patients with chronic NTM-LD, further analyses of their phenotypes are necessary to determine the significance of these findings.
Keywords: Leukocytes, Lung, Non-tuberculous mycobacteria, Pseudomonas aeruginosa, Lymphocytes
INTRODUCTION
The radiographic manifestations of non-tuberculous mycobacterial lung disease (NTM-LD) is often classified into three main types although overlaps may be seen: (i) nodules and bronchiectasis (“nodular-bronchiectasis disease”) that often involve the right middle lobe, lingula, and/or right upper lobe, (ii) nodular-bronchiectasis pattern with cavitation in one or more of the nodules, and (iii) fibrocavitary disease affecting the upper lobes in the setting of underlying emphysema. Other radiographic features of NTM-LD include inflammatory bronchiolitis manifesting as branching centrilobular nodules (tree-in-bud opacities), atelectasis, ground glass opacities, and/or consolidation.
Correlation of these radiographic features with histopathology can provide greater insights into the cellular pathogenesis of NTM-LD (1,2,3). For example, in resected lung tissues, computed tomography (CT) findings of bronchiectasis and bronchiolitis correlated with peribronchial and peribronchiolar granulomatous inflammation, respectively, as well as with airway wall necrosis (1). Lung nodules and cavity walls were also found to be comprised of caseating granulomas; interestingly, the outer rim of cavity walls may be surrounded by myofibroblasts, the differentiation of which requires the immunosuppressive cytokine TGF-β (1).
More detailed analysis of the lung cellular composition may shed further light on the pathogenesis of NTM-LD. When examining lung histopathologic tissues of those NTM-LD, we observed prominent infiltration by numerous lymphocytes but could not find in the literature characterization of their phenotypes. Surgical resection of non-tuberculous mycobacterial (NTM) diseased segment or lobe (or sometimes an entire lung) is routinely executed in some centers (4,5). While prospective, randomized control studies have not been performed on such treatment, surgical resection in selected patients – typically those with severe but localized disease – have been associated with improved microbiologic outcome (6,7,8,9). Surgical lung resection has also been shown to be salubrious for individuals with multi-drug resistant tuberculosis (10,11). While standard histopathologic analyses can provide information on the major cell types and the architecture of the pathology, it does not discriminate stringently or quantify the immune cell phenotypes involved in the pathologic process. Indeed, we are unaware of detailed cellular analyses in the actual lung tissues of pulmonary NTM patients. Thus, we undertook a pilot study to analyze and correlate the radiographic, histopathologic, and immune cell phenotypes, the lattermost as determined by flow cytometry, of the surgically-removed lung tissues of six patients with NTM-LD and compared the findings to that of two patients with chronic Pseudomonas aeruginosa lung disease (PsA-LD). In this study, large numbers of smaller lymphocytes, comprised of CD4+ T cells, CD8+ T cells, and both CD16+ and CD56+ NK cells were found in NTM-LD. Infiltration by CD19+ B cells varied widely. Contrary to our expectations, there were relatively few neutrophils in the lung tissues.
MATERIALS AND METHODS
Patient identification
Following Institutional Review Board approval (National Jewish Health HS# 3137), six patients with NTM-LD were prospectively identified to be undergoing lung resection. For comparison, two patients with chronic PsA-LD but no history of NTM-LD who were having lung resection were also included. Each patient underwent lung surgery as part of their recommended treatment.
CT scan and lung histopathologic images
The pre-surgical chest CT scan closest to the time of the surgery and the surgical histopathology were analyzed. The histopathologic slides of the post-surgical lung specimens sent to the Pathology Department and prepared by the clinical histopathology laboratory were examined and representative images were obtained.
Procurement of fresh lung tissues
For each surgically removed lung specimen, two-1 cm3 lung pieces were excised in the operating room from areas that visually appeared to be less affected ("less-diseased") and two pieces from areas that appeared severely affected ("more-diseased"). The lung tissues were immediately placed in cold Hanks Buffered Saline Solution, kept at 4oC, and processed for flow cytometry within 24 h.
Flow cytometry and gating scheme
From each pair of less-diseased and more-diseased samples, one piece was fixed and stained for histology with H&E. The other paired lung tissue samples were digested in ~2 units DNAse I, ~5 mg collagenase, and 10 ml RPMI buffer with no serum. Five ml was used for each tissue sample and digested for 30 min at 37oC with occasional mixing. The digestion was stopped with addition of 5 ml cold RPMI (4oC) with 10% FBS, the cells separated from the larger tissue matrix debris through a 70 µm filter, and the recovered cells centrifuged and counted on a hemocytometer. A total of 200,000 cells were stained in each tube for extracellular markers and live/dead cells. Cell surface markers were used to identify granulocytes (SSChighCD14−CD66b+), macrophages (SSChighCD14+CD66b−), monocytes (SSCmediumCD14+CD66b−), large lymphocytes (SSChigh/medium), and small lymphocytes (SSClow) as well as lymphocytic phenotypes NK cells (SSChigh, CD16high vs. CD56+), T cells (CD3+, CD4+, CD8+, pan-gamma/delta T cell receptor+), and B cells (CD19+). Cells were fixed and collected on a Becton Dickinson FACS Canto II, and the data analyzed by FloJo.
We gated first on forward scatter and side scatter, followed by CD45 and live-dead violet to find the live CD45+ populations. Forward and side scatter plots were also used to examine relative granularity and size of each cell population.
Statistics
Data were analyzed in Prism 8.2 with paired t-test statistics to each subset, comparing paired (less-diseased vs more-diseased) samples from each patient.
RESULTS AND DISCUSSION
Demographics, NTM species, and type of lung resection
The gender, age at the time of surgery, key past medical history, the peripheral white blood cell count and differential closest to the time of surgery, the responsible NTM species, and the resected part of the lung are recorded in Table 1. All the patients were women and Mycobacterium avium complex (MAC) species accounted for all of the NTM-LD analyzed. Similar demographic information was also recorded for the two patients with PsA-LD (Table 1). The peripheral white blood cell count was within normal limits in all patients except for patient B, where it was only very slightly elevated. The percent neutrophils and lymphocytes in the peripheral blood were essentially within normal limits.
Table 1. Clinical, microbiologic, and surgical data of six subjects with NTM-LD and two with PsA-LD.
Patient | Age (yr), sex | Past medical history | WBC and differential* (cells/L & %) | NTM species | Lung segment or lobe removed |
---|---|---|---|---|---|
A | 49F | PiMZ, GERD, esophageal dyskinesia, vitamin D deficiency, vitiligo | 5.9×109 | M. intracellulare & M. yongonense | Posterior segment of RUL |
P59L27M7E6 | |||||
B | 67F | Prior left apical lung segmentectomy, cardiomyopathy, emphysema, esophageal dyskinesia, GERD, hypertension, fibromuscular dysplasia, hypothyroidism, LBBB, SS-B Ab (+) | 11.4×109 | M. intracellulare | Completion left pneumo-nectomy |
P77L12M9E1 | |||||
C | 37F | Chronic sinusitis | 10×109 | Macrolide-resistant MAC | RUL |
P70L18M9E3 | |||||
D | 64F | Asthma, GERD, depression, rheumatic fever, osteoporosis, mitral valve prolapse, scoliosis, hearing loss | 5.8×109 | M. intracellulare | LLL |
P70L18M9E3 | |||||
E | 61F | Asthma, GERD, irritable bowel syndrome, depression, osteoporosis | 7.7×109 | MAC | Lingula |
P75L11M11 | |||||
F | 65F | GERD, hypothyroidism | 9.5×109 | MAC | RML |
P66L20M12E1 | |||||
G | 74F | Chronic P. aeruginosa lung infection, esophageal dyskinesia, GERD, hypothyroidism | 8.4×109 | No history of NTM | RML |
P75L11M11 | |||||
H | 63F | Chronic P. aeruginosa lung infection, allergic rhinitis, GERD, sicca syndrome (SS-A Ab +), hypothyroidism, sinusitis | 8.6×109 | No history of NTM | Lingula |
P70L18M10E3 | SS-LLL |
GERD, gastroesophageal reflux disease; LBBB, left bundle branch block; LLL, left lower lobe; PiMZ, protease inhibitor MZ phenotype; RML, right middle lobe; RUL, right upper lobe; SS, superior segment; WBC, white blood cell (normal WBC range [4–10×109/L].
*Normal neutrophil percent range (42%–78%) and normal lymphocyte percent range (13%–41%).
Correlation of high-resolution CT scan with histopathology
The most representative axial chest CT image and the key histopathologic photomicrograph (H&E) for each of the NTM-LD patients are shown in Fig. 1. Of the six patients with NTM-LD, five were classified as having nodular-bronchiectasis pattern on chest CT and one had fibrocavitary disease. Histopathologically, necrotizing granuloma were seen in four (Fig. 1A-D), non-necrotizing granuloma were seen in one (Fig. 1E), and dilated small airways with peribronchiole and/or intraluminal inflammation were seen in all although may not be apparent in the photomicrographs shown. Two lung specimens were notable for relatively large, discrete nodules composed of necrotizing granulomas (Fig. 1C and D). Of the two patients with chronic PsA-LD, nodular-bronchiectasis were seen in both (Fig. 1G and H); histopathologic analysis was notable for dilated bronchioles with surrounding fibrosis with peribronchiole and intraluminal inflammation but no granulomas. Additional CT images and histopathologic photomicrographs for each of these eight patients are shown in Supplementary Figs. 1, 2, 3, 4, 5, 6, 7, 8. It is important to emphasize that the histopathologic images shown in Figs. 1 and 2 and in the Supplementary Figures were from histopathology slides prepared by the clinical pathology laboratory at the University of Colorado Anschutz Medical Campus as part of the clinical pathologic evaluation.
Separate pieces of lung tissues obtained for flow cytometric analysis were also prepared with H&E staining for histopathologic analysis. We found that there was a very substantial mononuclear population, many of them relatively small lymphocytes (Fig. 2). These cells were found in clusters or scattered among largely fibrotic tissue and were more abundant in more-diseased areas. It was also quite apparent that neutrophils were not a significant component of the infiltrate, which is actually not inconsistent with the bronchoalveolar lavage (BAL) analysis of stable MAC lung disease wherein macrophages were found in greater numbers than lymphocytes and both greater than neutrophils (12).
Flow cytometric analyses
For the flow cytometric analyses, two different Ab panels were used, one for the major leukocyte subsets and the other for the major lymphocyte subsets with conventional markers (13). For the NTM-LD tissues, analysis revealed that both the percentage and absolute number of neutrophils were the lowest among all cell types examined in both the less-diseased and more-diseased samples with no significant difference between the two areas (Fig. 3A and B). While macrophage and monocyte numbers were higher than for the neutrophils, there was no quantitative difference in each of these two mononuclear cell types between the less- and more-diseased samples. There was a trend toward greater absolute number of large lymphocytes in the more-diseased areas (Fig. 3B). Significantly greater percentage of small lymphocytes were seen in the more-diseased samples compared to the less-diseased areas, and a trend toward greater absolute numbers (Fig. 3A and B). Both CD16+ and CD56+ NK cells could be found in relatively large numbers, but there no significant difference between the less- and more-diseased tissues.
For the two PsA-LD surgical samples, neutrophils were also the least prevalent immune cells in both the less- and more-diseased samples. Indeed, neutrophils in the PsA-LD were not only fewer than NTM-LD, but the more-diseased areas actually had lower number of neutrophils than the less-diseased samples albeit only two PsA-LD samples were analyzed. We also confirmed, using CD66b, that there were very few neutrophils compared to other subsets (data not shown). There were no differences in the number of macrophages, monocytes, and large lymphocyte populations but there was greater number of small and large lymphocytes in the more-diseased tissues of the PsA-LD samples.
Analyzing in greater depth the lymphocyte population in the NTM-LD samples, there were no significant differences in the percentage of the T cell subtypes between the less- and more-diseased areas (Fig. 4A); however, generally, there were greater absolute numbers of CD4+ T cells, CD8+ T cells, and gamma-delta T cells in the more-diseased than the less-diseased tissues (Fig. 4B). CD19+ B cells varied widely but there was significantly greater percentage of B lymphocytes and a clear trend toward greater absolute numbers in the more-diseased areas (Fig. 4A and B). Both CD16+ and CD56+ NK cells could be found in large numbers, but there no significant difference between the less- and more-diseased tissues. For the PsA-LD samples, there was relatively fewer CD4+ T cells, CD8+ T cells, gamma-delta T cells, and B cells (compared to the NTM-LD tissues) with no difference between the less-diseased vs. more-diseased tissues. The number of CD16+ and CD56+ NK cells in the PsA-LD tissues were similar to that for NTM-LD samples but such comparisons are preliminary given only two PsA-LD samples were available.
Han et al. (14) determined the phenotype of blood CD4+ T cells in 71 patients with NTM-LD due to MAC and 20 healthy controls following stimulation of their PBMC with heat-killed MAC. Compared to cells from control subjects, the stimulated PBMC of patients with MAC lung disease had decreased total CD4+ T cells and decreased TH17 cells but there were increased number of TH2 cells (CD4+IL-4+), Tregs, and CD4+ T cells that expressed deactivation or exhaustion markers PD-1, CTLA-4, and TIM-3. While this study of blood cells provides a systemic glimpse into the distribution of CD4+ T cell phenotypes, it does not provide information on what is happening in the lung compartment. Another limitation of this study (and ours) is that because the analyses of blood (and tissues) were done in individuals with established NTM-LD, we are unable to answer whether differential infiltration of these cellular phenotypes were present before the initial infection or whether they were the result of the infection. However, an advantage of profiling blood immune cells is that it provides an opportunity to phenotype over time the immune cells during the disease course, an endeavor not feasible by repeated lung tissue biopsies.
A semi-invasive way to assess the cell types in the lungs is by BAL, providing a means to analyze the detachable cells in the medium/smaller size airways and the alveolar space. With either localized or military tuberculosis, BAL have demonstrated increased percentage of neutrophils and lymphocytes as well as relative decrease in macrophages; in contrast, the peripheral blood showed the opposite pattern of decreased number of lymphocytes and increased number of monocytes (15,16). In addition, there was found a higher percentage in the BAL of CD4+ T cells and lower percentage CD8+ T cells (and opposite findings in peripheral blood) of patients with higher clinical grade of pulmonary tuberculosis – defined by extent of lung involvement and presence of fever and weight loss (17). NTM-LD is typically associated with relative increased percentage of lymphocytes and neutrophils in the BAL fluid (18). With MAC-associated nodular bronchiectasis, patients who were “not deteriorating” (n=8) had increased lymphocyte and neutrophils but macrophages remained the dominant cell population; i.e., macrophages > lymphocytes > neutrophils; in contrast, of those who were “deteriorating” (n=13), the relative percentages were neutrophils ≥ macrophages > lymphocytes (12). In 37 MAC lung disease subjects, those with neutrophil-dominant BAL had more severe radiographic disease and greater clinical deterioration than those with lymphocyte-dominant BAL (19).
In our analysis of the lung tissues of those with chronic NTM-LD, we predicted the presence of abundant inflammatory cells typically associated with chronic infections such as macrophages and lymphocytes but also neutrophils given the purulent nature of expectorated sputa and associated bronchiectasis. We found a substantial infiltration of lymphocytes into heavily diseased tissue, across the whole spectrum in most cases, and fewer neutrophils. This distribution pattern is consistent with the chronic nature of NTM-LD in our patients. Furthermore, despite the severity of the localized lung disease in the patients examined, clinical control of the infection with antibiotics is a prerequisite prior to lung resection. This clinical stipulation may also account for the fewer neutrophils found; i.e., the NTM infections in our patients were under control and surgery was performed to remove the irreversibly destroyed lung tissue, a potential nidus for future infections. The presence of clusters of CD4+ T cells, CD8+ T cells, and NK lymphocytes, their relatively small size, and dense nuclear stain all suggest that these cells are recent immigrants and perhaps is a de novo lymphocytic tissue organization, possibly a pseudo-lymphoid follicle.
Future studies should examine the subtypes of macrophages and dendritic cells but also for T and B cell immunophenotypes, including aged B cells, which have been found in increased number in the BAL of patients with sarcoidosis, beryllium disease, and hypersensitivity pneumonitis and may play a role in the pathogenesis of these granulomatous disease (20). “M1” (IFN/IL-12) skewed macrophages are considered to be host-protective through their effector functions of killing mycobacteria, participating in granuloma formation, and orchestrating other components of the immune system via presenting Ags and elaborating cytokines and chemokines that recruit and activate other cell types. The alternatively activated “M2 subtypes” are also important in a temporal fashion because they are necessary to dampen the immune response and repair the lung injury once the infection is under control. A similar paradigm may be made for the T effector cells such as the TH1 and TH17 cells that are necessary during the acute phase of the infection and the TH2 and Tregs that are required to quell the inflammation once bacterial killing is achieved. The high numbers of CD8 T cells and NK cells in these tissues suggests a TH1 response, but it’s not clear why they would persist if they are indeed skewed to this phenotype. Given the large amount of tissue destruction, perhaps they are still active. There are also regions of fibrosis. There is evidence that TH2, TH17, and Tregs contribute to alternative activation of macrophages (21,22,23), perhaps contributing to the chronic inflammation and airway fibrosis that is typically seen on CT scans and lung tissues of patients with NTM-LD.
Clearly there is a role for NK cells in the immune response in the lungs (24), and by the nature of the cytotoxicity, they may be major inducers of the massive destruction seen in both chronic NTM-LD and PsA-LD pathology. Future studies can also examine the four phenotypes of NK cells that have been described thus far (24). It is also important to note that some CD56+ and CD16+ cell types are not NK cells, but other lymphocytes. Likewise, a more detailed analysis of the sub-populations and phenotypes of all lymphocytes in this response would likely yield much greater insight into the immune response and potential therapeutic targets.
While it would be informative to have analysis of earlier lesions of NTM-LD, it is uncommon to have surgical biopsies of such lesions but even if they are available, allocation of the small pieces of lung tissues for clinical pathological analysis will likely result in inadequate amount of tissues available for research use. However, correlating the cellular phenotype of blood, BAL, and surgical lung tissue will likely be informative but the BAL will have to be done at least one week prior to the surgery or immediately prior to surgery (in the operating room) as the saline instillation itself for the BAL may incite an inflammatory response. While the value of blood analysis is that it can be obtained much earlier in the course of the illness and prospectively followed, the disadvantage is that it is not the lung environment.
In summary, in stable NTM-LD patients who underwent lung resection to remove a potential nidus for future exacerbations, the lung tissues contained significantly more small lymphocytes than macrophages or monocytes, and both cell populations outnumbered the neutrophils. The lymphocyte population of CD4+ T cells, CD8+ T cells, gamma-delta T cells, and B cells were also more prevalent in the more-diseased tissues but there was no such differential distribution in the NK cells.
Abbreviations
- BAL
bronchoalveolar lavage
- CT
computed tomography
- MAC
Mycobacterium avium complex
- NTM
non-tuberculous mycobacterial
- NTM-LD
non-tuberculous mycobacterial lung disease
- PsA-LD
Pseudomonas aeruginosa lung disease
Footnotes
Conflict of Interest: The authors declare no potential conflicts of interest.
- Conceptualization: Schenkel AR, Ordway D, Chan ED.
- Data curation: Schenkel AR, Mitchell JD, Cool CD, Chan ED.
- Formal analysis: Schenkel AR, Cool CD.
- Funding acquisition: Ordway D.
- Investigation: Schenkel AR, Mitchell JD, Cool CD, Bai X, Groshong S, Koelsch T, Verma D, Ordway D, Chan ED.
- Methodology: Schenkel AR, Mitchell JD, Cool CD, Bai X, Groshong S, Koelsch T, Verma D, Ordway D, Chan ED.
- Resources: Mitchell JD, Cool CD, Bai X, Groshong S, Koelsch T, Verma D, Ordway D, Chan ED.
- Writing - original draft: Schenkel AR, Ordway D, Chan ED.
- Writing - review & editing: Schenkel AR, Mitchell JD, Cool CD, Bai X, Groshong S, Koelsch T, Verma D, Ordway D, Chan ED.
SUPPLEMENTARY MATERIALS
References
- 1.Fujita J, Ohtsuki Y, Suemitsu I, Shigeto E, Yamadori I, Obayashi Y, Miyawaki H, Dobashi N, Matsushima T, Takahara J. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J. 1999;13:535–540. doi: 10.1183/09031936.99.13353599. [DOI] [PubMed] [Google Scholar]
- 2.Kim TS, Koh WJ, Han J, Chung MJ, Lee JH, Lee KS, Kwon OJ. Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation. AJR Am J Roentgenol. 2005;184:1247–1252. doi: 10.2214/ajr.184.4.01841247. [DOI] [PubMed] [Google Scholar]
- 3.Moore EH. Atypical mycobacterial infection in the lung: CT appearance. Radiology. 1993;187:777–782. doi: 10.1148/radiology.187.3.8497629. [DOI] [PubMed] [Google Scholar]
- 4.Yu JA, Pomerantz M, Bishop A, Weyant MJ, Mitchell JD. Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease. Eur J Cardiothorac Surg. 2011;40:671–675. doi: 10.1016/j.ejcts.2010.12.028. [DOI] [PubMed] [Google Scholar]
- 5.Mitchell JD. Surgical treatment of pulmonary nontuberculous mycobacterial infections. Thorac Surg Clin. 2019;29:77–83. doi: 10.1016/j.thorsurg.2018.09.011. [DOI] [PubMed] [Google Scholar]
- 6.Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011;52:565–571. doi: 10.1093/cid/ciq237. [DOI] [PubMed] [Google Scholar]
- 7.Pezzia W, Raleigh JW, Bailey MC, Toth EA, Silverblatt J. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. Rev Infect Dis. 1981;3:1035–1039. doi: 10.1093/clinids/3.5.1035. [DOI] [PubMed] [Google Scholar]
- 8.Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Koh WJ. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180:896–902. doi: 10.1164/rccm.200905-0704OC. [DOI] [PubMed] [Google Scholar]
- 9.Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71:905–913. doi: 10.1093/cid/ciaa1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, et al. Collaborative group for meta-analysis of individual patient data in MDR-TB. Surgery as an adjunctive treatment for multi-drug resistant tuberculosis: an individual patient data meta-analysis. Clin Infect Dis. 2016;62:887–895. doi: 10.1093/cid/ciw002. [DOI] [PubMed] [Google Scholar]
- 11.Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M, Iseman MD. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004;169:1103–1109. doi: 10.1164/rccm.200308-1159OC. [DOI] [PubMed] [Google Scholar]
- 12.Yamazaki Y, Kubo K, Takamizawa A, Yamamoto H, Honda T, Sone S. Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. Am J Respir Crit Care Med. 1999;160:1851–1855. doi: 10.1164/ajrccm.160.6.9902019. [DOI] [PubMed] [Google Scholar]
- 13.Tighe RM, Redente EF, Yu YR, Herold S, Sperling AI, Curtis JL, Duggan R, Swaminathan S, Nakano H, Zacharias WJ, et al. Improving the quality and reproducibility of flow cytometry in the lung. An Official American Thoracic Society Workshop Report. Am J Respir Cell Mol Biol. 2019;61:150–161. doi: 10.1165/rcmb.2019-0191ST. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Han SA, Ko Y, Shin SJ, Jhun BW. Characteristics of circulating CD4+ T cell subsets in patients with Mycobacterium avium complex pulmonary disease. J Clin Med. 2020;9:E1331. doi: 10.3390/jcm9051331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ozaki T, Nakahira S, Tani K, Ogushi F, Yasuoka S, Ogura T. Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis. Chest. 1992;102:54–59. doi: 10.1378/chest.102.1.54. [DOI] [PubMed] [Google Scholar]
- 16.Sharma SK, Pande JN, Verma K. Bronchoalveolar lavage (BAL) in miliary tuberculosis. Tubercle. 1988;69:175–178. doi: 10.1016/0041-3879(88)90018-9. [DOI] [PubMed] [Google Scholar]
- 17.Tsao TC, Chen CH, Hong JH, Hsieh MJ, Tsao KC, Lee CH. Shifts of T4/T8 T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest. 2002;122:1285–1291. doi: 10.1378/chest.122.4.1285. [DOI] [PubMed] [Google Scholar]
- 18.Yamazaki Y, Kubo K, Sekiguchi M, Honda T. Analysis of BAL fluid in M. avium-intracellulare infection in individuals without predisposing lung disease. Eur Respir J. 1998;11:1227–1231. doi: 10.1183/09031936.98.11061227. [DOI] [PubMed] [Google Scholar]
- 19.Inomata T, Konno S, Nagai K, Suzuki M, Nishimura M. Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection. PLoS One. 2018;13:e0190189. doi: 10.1371/journal.pone.0190189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Phalke S, Aviszus K, Rubtsova K, Rubtsov A, Barkes B, Powers L, Warner B, Crooks JL, Kappler JW, Fernández-Pérez ER, et al. Age-associated B cells appear in patients with granulomatous lung diseases. Am J Respir Crit Care Med. 2020;202:1013–1023. doi: 10.1164/rccm.201911-2151OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gieseck RL, 3rd, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18:62–76. doi: 10.1038/nri.2017.90. [DOI] [PubMed] [Google Scholar]
- 22.Paun A, Bergeron ME, Haston CK. The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease. Sci Rep. 2017;7:11586. doi: 10.1038/s41598-017-11656-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chakraborty K, Chatterjee S, Bhattacharyya A. Impact of Treg on other T cell subsets in progression of fibrosis in experimental lung fibrosis. Tissue Cell. 2018;53:87–92. doi: 10.1016/j.tice.2018.06.003. [DOI] [PubMed] [Google Scholar]
- 24.Theresine M, Patil ND, Zimmer J. Airway natural killer cells and bacteria in health and disease. Front Immunol. 2020;11:585048. doi: 10.3389/fimmu.2020.585048. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.